A Pilot Study to assess Theragnostically Planned Liver Radiation with Functional DVH Analysis to Optimize Individualized Radiation Therapy
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Hepatocellular Carcinoma | Cholangiocarcinoma | liver cancer
Age: Between 18 - 100 Years
Gender: Male or Female
Primary liver malignancy including hepatocellular carcinoma (HCC) or cholangiocarcinoma
Subjects must have a Child-Turcotte-Pugh (CTP) score less than or equal to 7
Subject who are pregnant or planning to become pregnant during the study
No more than 3 lesions can be treated. Total diameter of all lesions must be less than or equal to 6 cm
Prior radiation treatment to the upper abdomen
Active infection, active upper GI ulceration or hemorrhage, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required